Lydimycin

Overview

Lydimycin (α-DHB; α-Dehydrobiotin) is an antibiotic produced by Streptomyces lydicus , with antibacterial , antifungal and antiviral activities. Lydimycin inhibits the binding of SARS-CoV-2 S-614G spike protein to human ACE2 . The antibacterial activity of Lydimycin can be reversed by Biotin ( HY-B0511 ) in the culture medium. Lydimycin is applicable to infection-related research.

Application

Products | Products > Disease Areas > Fungal Infection | Products > Disease Areas > Infection | Products > Disease Areas > Coronavirus Infection | Products > Disease Areas > Bacterial Infection | Products > Signaling Pathways > Anti-infection | Products > Research Areas > Infection | Products > Signaling Pathways > Antibiotic | Products > Signaling Pathways > Bacterial | Products > Signaling Pathways > Fungal | Products > Signaling Pathways > SARS-CoV

Product Information

• Catalog No.: HY-105801
• CAS No.: 10118-85-1
• Molecular Formula: C10H14N2O3S
• Molecular Weight: 242.29
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source